BSE filing, NSE: SANCTRN. Summary written from the filing by ALFA Finder's alert engine.
Sanco Trans Ltd: key numbers
- Share price
- ₹667.80
- Market cap
- ₹120.2 Cr
- Revenue (annual)
- ₹139.0 Cr
- Net profit (annual)
- ₹10.08 Cr
- P/E (TTM)
- 11.9×Sector 30.1×
- Promoter holding
- 72.52%+0.03% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sanco Trans Ltd
All →Sanco Trans Legal & Regulatory
Sanco Trans received a Customs order from the Trichy Commissioner for Rs. 15.98 Lakhs recovery, interest and penalty over alleged wrong duty drawback. The company is contesting it before appropriate legal forums.
- Value
- ₹0.16 Cr
Sanco Trans Other Announcement
Sanco Trans Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a periodic regulatory compliance disclosure.
Sanco Trans Q1 FY27 Results: Net Profit ₹1.7 Cr, Up 0.0% YoY
Sanco Trans Ltd reported revenue from operations of ₹38 Cr (+13.1% YoY) and net profit of ₹1.7 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.7 Cr · +0.0% YoY
Sanco Trans Board Meeting Date
Sanco Trans Ltd has scheduled a Board Meeting for August 12, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Sanco Trans Annual General Meeting
Sanco Trans Limited held its 46th Annual General Meeting on July 29, 2026. The meeting covered the adoption of financial statements, dividend declaration, and director re-appointment.
Sanco Trans Annual Report
Sanco Trans Ltd filed its FY 2025‑26 Annual Report and AGM notice with BSE. The filing complies with SEBI Regulation 34(1).
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.